Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study
Article in Metabolic Brain Disease (June 2024)
The most recent citing publications are shown below. View all 191 publications that cite this research output on Dimensions.
Article in Metabolic Brain Disease (June 2024)
Article in Clinical Proteomics (June 2024)
Article in JAMA Network Open (June 2024)